---
title: "BeiGene Terminates Early-Stage Solid Tumor Trial, Shifting Risk Focus for Oncology Investors"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/279072345.md"
description: "BeiGene Terminates Early-Stage Solid Tumor Trial, Shifting Risk Focus for Oncology Investors"
datetime: "2026-03-13T16:30:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279072345.md)
  - [en](https://longbridge.com/en/news/279072345.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279072345.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/279072345.md) | [English](https://longbridge.com/en/news/279072345.md)


# BeiGene Terminates Early-Stage Solid Tumor Trial, Shifting Risk Focus for Oncology Investors

BeiGene Terminates Early-Stage Solid Tumor Trial, Shifting Risk Focus for Oncology Investors

### 相關股票

- [BEONE MEDICINES (06160.HK)](https://longbridge.com/zh-HK/quote/06160.HK.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [BeOne Medicines (688235.CN)](https://longbridge.com/zh-HK/quote/688235.CN.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [Beigene (BGNE.US)](https://longbridge.com/zh-HK/quote/BGNE.US.md)
- [Direxion S&P Biotech Bull 3X (LABU.US)](https://longbridge.com/zh-HK/quote/LABU.US.md)

## 相關資訊與研究

- [Lantern receives FDA clearance for paediatric STAR-001 CNS trial](https://longbridge.com/zh-HK/news/281102581.md)
- [MAIA's Phase 2 Trial Shows Eight Lung Cancer Patients Surpassing Two Years Of Survival](https://longbridge.com/zh-HK/news/281329946.md)
- [Vertex Pharmaceuticals Inc - FDA expands indication for trikafta in cf patients ages 2 and older](https://longbridge.com/zh-HK/news/281371049.md)
- [Iterum Therapeutics Announces Filing of Winding Up Petition | ITRM Stock News](https://longbridge.com/zh-HK/news/280800007.md)
- [Precigen Details Papzimeos Commercial Launch, Hub Growth and J-Code Catalyst at H.C. Wainwright Chat](https://longbridge.com/zh-HK/news/281233412.md)